Telemedicine, the use of telecommunication technology to remotely provide health care services, is an emerging interest for clients in the FDA sector. For example, many FDA-regulated companies are now using internet platforms to engage with patients and potential customers. The use of the internet in this context touches on FDA regulations, CLIA, state law requirements, and a host of other issues. This presentation will introduce issues to consider when advising clients interested in exploring telemedicine as a new business opportunity or as a component of an existing platform.
- Rachael E. Hunt, Associate, Hyman, Phelps, & McNamara PC
- Serra J. Schlanger, Associate, Hyman, Phelps, & McNamara PC
Hyman, Phelps, & McNamara PC, 700 13th St. NW #1200, Washington, DC 20005
This program is limited to those who are a part of NFDL. This complimentary program includes a light lunch. Please register by February 18 to reserve your spot.
New to Food and Drug Law Group
The New to Food and Drug Law Group (NFDL) offers young professionals with up to six years of experience an opportunity to connect, learn from their peers, and enhance their skills. Individuals affiliated with member organizations, those employed by the government, and law students are encouraged to participate.
For questions, please contact Paige Samson.